Ambee Pharmaceuticals PLC (DSE: AMBEEPHA)

Market Cap	2.36B
Revenue (ttm)	205.24M
Net Income (ttm)	10.68M
Shares Out	2.40M
EPS (ttm)	4.45
PE Ratio	221.08
Forward PE	n/a
Dividend	1.50 (0.15%)
Ex-Dividend Date	n/a

Volume	9,590
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	650.00 - 1,302.30
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 12, 2024

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. The company offers products in various therapeutic areas, including analgesic and antipyretic, anti-helmintic, antacid, anti-histamine, anti-protozoal and anti-fungal, antiasthmatic and antitussive, antibacterial, anticonvulstant, antiemetic, antihypertensive, antilipidemic agents, antiosteoarthritic, antispasmodic, antituberculer, antiulcerant, anxiolytic and hypnotic, cerebral vasodilator, corticosteroid...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 477
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AMBEEPHA

Financial Performance

In 2023, Ambee Pharmaceuticals's revenue was 198.10 million, an increase of 9.45% compared to the previous year's 180.99 million. Earnings were 9.09 million, an increase of 12.79%.